Lilly CEO Ricks Promises Sanders Not to Raise Insulin Prices (1)

Eli Lilly & Co. won’t raise prices on any insulin products now on the market, Chief Executive Officer Dave Ricks told Senator Bernie Sanders at a hearing with big pharma executives as drugmakers come under increased scrutiny over soaring costs.

Ricks was the only executive to agree outright to some of Sanders’ demands at the hearing called by the senator as lawmakers discuss bills to cap insulin costs. Ricks, along with CEOs of Sanofi and Novo Nordisk A/S, wouldn’t accede to Sanders’ other requests, such as lowering list prices on other drugs that cost less in Europe, including Novo’s ...